MENU
+Compare
NVS
Stock ticker: NYSE
AS OF
Feb 4, 04:59 PM (EDT)
Price
$105.47
Change
-$0.01 (-0.01%)
Capitalization
197.93B

NVS Novartis AG Forecast, Technical & Fundamental Analysis

a manufacturer of health care and nutritional products

NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NVS with price predictions
Feb 03, 2025

NVS in upward trend: 10-day moving average broke above 50-day moving average on January 30, 2025

The 10-day moving average for NVS crossed bullishly above the 50-day moving average on January 30, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 27, 2025. You may want to consider a long position or call options on NVS as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

NVS moved above its 50-day moving average on January 27, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVS advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 296 cases where NVS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

NVS broke above its upper Bollinger Band on January 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.200) is normal, around the industry mean (5.632). P/E Ratio (23.383) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (5.223) is also within normal values, averaging (3.004). Dividend Yield (0.039) settles around the average of (0.164) among similar stocks. P/S Ratio (4.299) is also within normal values, averaging (3.643).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NVS is expected to report earnings to fall 2.02% to $1.94 per share on April 29

Novartis AG NVS Stock Earnings Reports
Q1'25
Est.
$1.94
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.12
Q2'24
Beat
by $0.13
Q1'24
Beat
by $0.13
The last earnings report on January 31 showed earnings per share of $1.98, beating the estimate of $1.82. With 818.45K shares outstanding, the current market capitalization sits at 197.93B.
A.I.Advisor
published Dividends

NVS paid dividends on March 20, 2023

Novartis AG NVS Stock Dividends
А dividend of $3.70 per share was paid with a record date of March 20, 2023, and an ex-dividend date of March 09, 2023. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of health care and nutritional products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Lichtstrasse 35
Phone
+41 613241111
Employees
76057
Web
https://www.novartis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPNG23.580.07
+0.30%
Coupang
WYY3.80N/A
N/A
WidePoint Corp
INBK32.45-0.12
-0.37%
First Internet Bancorp
TGTX31.48-0.22
-0.69%
TG Therapeutics
PDFS27.14-0.72
-2.58%
PDF Solutions

NVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been loosely correlated with AZN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NVS jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
+0.73%
AZN - NVS
52%
Loosely correlated
-1.27%
SNY - NVS
39%
Loosely correlated
-1.82%
JNJ - NVS
38%
Loosely correlated
-0.18%
GSK - NVS
38%
Loosely correlated
-1.05%
RHHBY - NVS
37%
Loosely correlated
+0.18%
More